Status:
COMPLETED
MBSR on Nocturnal Hypertension
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Objectives: To examine the feasibility and acceptability of treating nocturnal hypertension by mindfulness-based stress reduction program (MBSR). This will provide data essential for the main trial, w...
Eligibility Criteria
Inclusion
- diagnosed hypertension (HT) from clinical records (with or without anti-hypertensive medications)
- nocturnal HT (night-time systolic blood pressure \[SBP\] during sleep ≥120 mmHg) and stage I hypertension (daytime SBP = 135-159 mmHg), as detected by 24-hour ambulatory blood pressure monitoring (ABPM)
- no change of dose and type of anti-hypertensive(s) in the prior 2 months
Exclusion
- patients with atrial fibrillation (these patients have greater blood pressure variability)
- daytime office systolic blood pressure (BP) ≥180 mmHg or diastolic BP ≥120 mmHg (regardless of nocturnal BP)
- patients with known obstructive sleep apnoea
- history of dementia or psychotic illnesses
- patients with end-stage malignancies
- nocturnal worker, because they will have a reverse BP pattern to other participants
- patients receiving ≥3 BP medications at maximal tolerated doses
- previous participation in structured mindfulness program(s) of ≥8 weeks or regular daily meditation practices
- reported sleep time of \<4 hours per day
- patients who do not agree to keep the same dose of anti-HT medications during the trial period
- patients receiving anti-coagulants
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06510907
Start Date
November 1 2023
End Date
December 31 2024
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of public health and primary care
Hong Kong, Hong Kong